trimethoprim

Trimethoprim (NSC-106568) is a Dihydrofolate Reductase Inhibitor Antibacterial. The mechanism of action of trimethoprim is as a Dihydrofolate Reductase Inhibitor, and Cytochrome P450 2C8 Inhibitor, and Organic Cation Transporter 2 Inhibitor.

Trimethoprim N-oxide is a human urinary metabolite.

Trimethoprim 3-oxide trimethoprim primary metabolite.

Trimethoprim lactate (NSC-106568 lactate) is an antibiotic that inhibits bacterial dihydrofolate reductase (DHFR). Trimethoprim lactate has demonstrated antimicrobial activity, with excellent inhibition of Gramnegative bacteria. Trimethoprim lactate is used alone for the Trimethoprim lactate is used alone or in combination with other antibiotics to treat a variety of eye, lung, and gastrointestinal infections.

Trimethoprim sulfate is a pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. The interference with folic acid metabolism may cause a depression of hematopoiesis. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.

Trimethoprim hydrochloride, a bacteriostatic antibiotic and dihydrofolate reductase inhibitor, demonstrates efficacy against a broad spectrum of Gram-positive and Gram-negative aerobic bacteria. It has research applications for urinary tract infections, Shigellosis, and Pneumocystis pneumonia. Additionally, when combined with zinc, it can inhibit the infection of Influenza A virus in chick embryos [1] [2] [3] [4].

Trimethoprim pentanoic acid is a hapten that exhibits an IC50 of 0.15 ng mL when its diaminopyrimidine moiety is exposed to the immune system [1].

Methyl EudesMate, synthesized from Gallic acid, has antioxidant activity and is commonly used in the production of sulfonamide synergist intermediates, trimethoprim (TMP) and many other drugs.

Sulfamethoxazole sodium (Ro 4-2130 sodium) is a sulfonamide bacteriostatic antibiotic.

Brodimoprim is an inhibitor of dihydrofolate reductase(DHFR). Brodimoprim is also a long-acting broad-spectrum antibacterial agent characterized by a good pharmacokinetic profile.

Ro 20-0657 000 is a metabolite of Trimethoprim, an inhibitor of dihydrofolate reductase and an antibacterial agent used in human and veterinary medicine.

Trimosulfa is a fixed antibiotic combination that widely used for mild-to-moderate bacterial infections and as prophylaxis against opportunistic infections.